Totaligent Revenue Plummets 99.5%; Going Concern Doubts Intensify

TL;DR

**TGNT is a burning dumpster fire; stay far away unless you like losing money.**

AI Summary

Totaligent, Inc. (TGNT) reported a significant decline in revenue for the nine months ended September 30, 2025, plummeting to $2,248 from $444,529 in the prior year, a 99.5% decrease. The company's net loss for the nine-month period improved slightly to $(490,889) from $(834,715) year-over-year, primarily due to a substantial reduction in operating expenses from $772,102 to $299,828. Key business changes include a significant decrease in consulting expenses from $337,905 to $18,436 and personnel expenses from $288,500 to $100,650. The company's cash position drastically fell from $22,128 at December 31, 2024, to $504 by September 30, 2025. Totaligent faces substantial doubt about its ability to continue as a going concern, evidenced by a net loss of $490,889, negative working capital of $2,204,434, and an accumulated deficit of $2,298,252 as of September 30, 2025. Strategic outlook involves seeking additional financing through debt or equity, with no assurances of success or favorable terms.

Why It Matters

Totaligent's near-total revenue collapse and precarious cash position signal extreme operational distress, making it a high-risk investment. For investors, the 'going concern' warning and negative working capital of $2.2 million mean potential for significant dilution or even bankruptcy. Employees face job insecurity given the drastic cuts in personnel and consulting expenses. In a competitive digital marketing landscape, Totaligent's inability to generate sustainable revenue suggests it's losing ground rapidly, impacting its ability to serve customers or innovate. The broader market should view this as a cautionary tale of micro-cap companies struggling to scale without adequate capital.

Risk Assessment

Risk Level: high — Totaligent exhibits a high risk level due to its 'going concern' warning, a net loss of $490,889 for the nine months ended September 30, 2025, and a negative working capital of $2,204,434. The company's cash balance of only $504 at September 30, 2025, further underscores its severe liquidity issues and dependence on external financing, which is not guaranteed.

Analyst Insight

Investors should avoid Totaligent (TGNT) given the severe financial distress, including a 99.5% revenue drop and significant going concern risk. Current shareholders should consider exiting their positions, as the likelihood of substantial dilution or complete loss of investment is high.

Financial Highlights

revenue

$2,248

total Assets

$285,955

net Income

$(490,889)

gross Margin

100.0%

cash Position

$504

revenue Growth

-99.5%

Key Numbers

• $2,248 — Revenue (9 months ended Sep 30, 2025) (Decreased 99.5% from $444,529 in the prior year)
• $(490,889) — Net Loss (9 months ended Sep 30, 2025) (Improved from $(834,715) in the prior year)
• $504 — Cash (as of Sep 30, 2025) (Decreased from $22,128 at Dec 31, 2024)
• $(2,204,434) — Negative Working Capital (as of Sep 30, 2025) (Indicates severe liquidity issues)
• $(2,298,252) — Accumulated Deficit (as of Sep 30, 2025) (Highlights historical losses)
• $18,436 — Consulting Expenses (9 months ended Sep 30, 2025) (Decreased from $337,905 in the prior year)
• $100,650 — Personnel Expenses (9 months ended Sep 30, 2025) (Decreased from $288,500 in the prior year)
• 211,101,313 — Common Shares Outstanding (as of Nov 14, 2025) (High share count for a company with low market value)
• $3.7 million — Aggregate Market Value (as of Sep 30, 2025) (Low market capitalization for non-affiliates)
• 99.5% — Revenue Decrease (YoY) (Percentage drop in revenue for the nine months ended September 30, 2025)

Key Players & Entities

• Totaligent, Inc. (company) — Registrant and parent company
• Digi Messaging & Advertising Inc. (company) — Wholly owned subsidiary of Totaligent
• Edward C. DeFeudis (person) — CEO of Totaligent
• Ben Hansel (person) — Board of Directors member of Totaligent
• SEC (regulator) — Securities and Exchange Commission
• $2,248 (dollar_amount) — Totaligent's revenue for the nine months ended September 30, 2025
• $444,529 (dollar_amount) — Totaligent's revenue for the nine months ended September 30, 2024
• $490,889 (dollar_amount) — Totaligent's net loss for the nine months ended September 30, 2025
• $2,204,434 (dollar_amount) — Totaligent's negative working capital as of September 30, 2025
• $504 (dollar_amount) — Totaligent's cash balance as of September 30, 2025

FAQ

Risk Factors

• Going Concern Uncertainty [high — financial]: Totaligent faces substantial doubt about its ability to continue as a going concern due to a significant net loss of $490,889 for the nine months ended September 30, 2025, negative working capital of $2,204,434, and an accumulated deficit of $2,298,252. The company's cash position has dwindled to $504 from $22,128.
• Drastic Revenue Decline [high — financial]: Revenue has plummeted by 99.5% to $2,248 for the nine months ended September 30, 2025, from $444,529 in the prior year. This severe drop indicates a potential collapse in the company's core business operations or market demand.
• Liquidity Crisis [high — financial]: The company's cash position has fallen to a critical $504 as of September 30, 2025, down from $22,128 at the end of 2024. Coupled with negative working capital of $2,204,434, this presents an immediate liquidity crisis.
• Dependence on Future Financing [high — financial]: Totaligent's strategic outlook is heavily reliant on securing additional financing through debt or equity. There are no assurances of success or that such financing will be obtained on favorable terms, exacerbating the going concern issue.
• Significant Cost Reductions [medium — operational]: Operating expenses have been drastically reduced from $772,102 to $299,828 for the nine-month period. This was driven by substantial cuts in consulting expenses (from $337,905 to $18,436) and personnel expenses (from $288,500 to $100,650), suggesting a significant scaling back of operations.
• Low Market Capitalization [medium — market]: The aggregate market value was $3.7 million as of September 30, 2025, with 211,101,313 common shares outstanding. This low market capitalization relative to the share count indicates a very low per-share valuation and potential investor disinterest.

Industry Context

The company operates in a sector that likely requires significant investment in research, development, and sales. Given the drastic revenue decline and operational scaling back, Totaligent appears to be struggling to maintain market share or find a viable business model. The competitive landscape is likely intense, demanding innovation and efficient resource allocation, which the company currently lacks.

Regulatory Implications

The severe financial distress and going concern warning necessitate significant disclosures to investors and regulators. Failure to secure financing could lead to bankruptcy proceedings, triggering various regulatory requirements and investor protection measures. The company must ensure all disclosures accurately reflect its precarious financial state.

What Investors Should Do

1. Avoid investment in Totaligent, Inc. due to extreme financial distress, including a near-total revenue collapse, critical cash shortage, and substantial going concern doubt.
2. Monitor any future financing announcements closely, as the terms and success of such efforts will be critical to the company's survival, but expect unfavorable terms or outright failure.
3. Review the company's strategy for addressing its accumulated deficit and negative working capital, as current trends indicate a high probability of insolvency.

Key Dates

• 2025-09-30: End of Nine-Month Period — Reporting period for the 10-Q, revealing a severe revenue decline, critical cash shortage, and going concern issues.
• 2024-12-31: End of Fiscal Year 2024 — Baseline for comparison, showing a cash balance of $22,128, which has since drastically reduced.

Glossary

Going Concern

An assumption that a company will continue to operate for the foreseeable future, typically at least 12 months. If substantial doubt exists, it must be disclosed. (Totaligent faces substantial doubt about its ability to continue as a going concern, indicating severe financial distress.)

Accumulated Deficit

The cumulative net losses of a company since its inception, minus any net profits. It represents a negative retained earnings balance. (Totaligent has an accumulated deficit of $2,298,252, highlighting a history of unprofitability.)

Working Capital

The difference between a company's current assets and current liabilities. Positive working capital indicates sufficient short-term assets to cover short-term liabilities. (Totaligent has negative working capital of $2,204,434, signaling a severe liquidity shortfall.)

Derivative Liability

A financial instrument whose value is derived from an underlying asset, which has a negative fair value for the reporting entity. (The company has a derivative liability of $221,589, which contributes to its current liabilities.)

Convertible Notes Payable

Debt instruments that can be converted into a predetermined amount of the issuer's equity at certain times during their life. (Totaligent has $911,335 in convertible notes payable, representing a significant short-term debt obligation.)

Year-Over-Year Comparison

Compared to the prior year, Totaligent has experienced a catastrophic 99.5% decline in revenue for the nine months ended September 30, 2025, falling from $444,529 to $2,248. While the net loss has improved from $(834,715) to $(490,889), this is primarily due to drastic cost-cutting measures, not revenue recovery. The company's cash position has evaporated from $22,128 to $504, and its working capital has turned severely negative, highlighting a significantly worsened financial condition.

Key Financial Figures

• $3.7 million — etplace on such date, was approximately $3.7 million. Shares of common stock held by each of
• $504 — ember 30, 2025, the Company had cash of $504. Management is currently seeking to rai

Filing Documents

• totaligent_10q.htm (10-Q) — 972KB
• totaligent_ex311.htm (EX-31.1) — 10KB
• totaligent_ex312.htm (EX-31.2) — 10KB
• totaligent_ex321.htm (EX-32.1) — 4KB
• totaligent_ex322.htm (EX-32.2) — 4KB
• 0001477932-25-008363.txt ( ) — 4376KB
• totaligent-20250930.xsd (EX-101.SCH) — 44KB
• totaligent-20250930_lab.xml (EX-101.LAB) — 230KB
• totaligent-20250930_cal.xml (EX-101.CAL) — 42KB
• totaligent-20250930_pre.xml (EX-101.PRE) — 197KB
• totaligent-20250930_def.xml (EX-101.DEF) — 95KB
• totaligent_10q_htm.xml (XML) — 722KB

– Financial Information

Part I – Financial Information 4 Item 1.

Financial Statements

Financial Statements 4 Consolidated Balance Sheets as of September 30, 2025 (unaudited) and December 31, 2024 F-1 Consolidated Statements of Operations for the Three and Nine Months Ended September 30, 2025 and 2024 (unaudited) F-2 Consolidated Statements of Stockholders' Deficit for the Three and Nine Months Ended September 30, 2025 and 2024 (unaudited) F-3-F-4 Consolidated Statements of Cash Flows for the Nine Months Ended September 30, 2025 and 2024 (unaudited) F-5 Notes to Unaudited Consolidated Financial Statements F-6 Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 5 Item 3. Qualitative and Quantitative Discussions about Market Risk 12 Item 4.

Controls and Procedures

Controls and Procedures 12

– Other Information

Part II – Other Information 13 Item 1.

Legal Proceedings

Legal Proceedings 13 Item 1A.

Risk Factors

Risk Factors 13 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 13 Item 3. Default Upon Senior Securities 13 Item 4. Mine Safety Disclosures 13 Item 5. Other Information 13 Item 6. Exhibits 14 2 SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS This document contains certain statements of a forward-looking nature. Such forward-looking statements, including but not limited to statements regarding projected growth, trends and strategies, future operating and financial results, financial expectations and current business indicators are based upon current information and expectations and are subject to change based on factors beyond the control of the Company. Forward-looking statements typically are identified by the use of terms such as "look," "may," "should," "might," "believe," "plan," "expect," "anticipate," "estimate" and similar words, although some forward-looking statements are expressed differently. The accuracy of such statements may be impacted by a number of risks and uncertainties that could cause actual results to differ materially from those projected or anticipated, including but not limited to those set forth herein and in our Annual Report on Form 10-K. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. Except as required by the federal securities laws, we undertake no obligation to update forward-looking information. Nonetheless, the Company reserves the right to make such updates from time to time by press release, periodic report or other method of public disclosure without the need for specific reference to this Report. No such update shall be deemed to indicate that other statements not addressed by such update remain correct or create an obligation to provide any other updates. 3 Table of Contents

– FINANCIAL INFORMATION

PART I – FINANCIAL INFORMATION

Financial statements

Item 1. Financial statements TOTALIGENT, INC. FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2025 INDEX TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

Financial Statements

Financial Statements Consolidated Balance Sheets at September 30, 2025 (Unaudited) and December 31, 2024 F-1 Consolidated Statements of Operations (Unaudited) for the Three and Nine Months ended September 30, 2025 and 2024 F-2 Consolidated Statements of Stockholders' Deficit (Unaudited) for the Three and Nine Months ended September 30, 2025 and 2024 F-3-F-4 Consolidated Statements of Cash Flows (Unaudited) for the Nine Months ended September 30, 2025 and 2024 F-5 Notes to Unaudited Consolidated Financial Statements F-6 4 Table of Contents TOTALIGENT, INC. AND SUBSIDIARY CONSOLIDATED BALANCE SHEETS September 30, 2025 December 31, 2024 (Unaudited) ASSETS Current assets Cash $ 504 $ 22,128 Prepaid expenses 7,500 6,452 Investment in securities 90,000 - Total current assets 98,004 28,580 Property and equipment, net 34,810 66,354 Capitalized software 153,141 127,991 Total assets $ 285,955 $ 222,925 LIABILITIES AND STOCKHOLDERS' DEFICIT Current liabilities Accounts payable $ - $ 7,000 Accrued compensation 996,198 988,697 Accrued interest 173,316 125,090 Convertible notes payable 911,335 681,335 Derivative liability 221,589 158,055 Total current liabilities 2,302,438 1,960,177 Total liabilities 2,302,438 1,960,177 Commitments and contingencies (Note 8) Stockholders' deficit Preferred stock, $ 0.01 par value; authorized – 10,000,000 shares Series D Preferred stock, authorized – 1,000,000 shares; issued and outstanding – 576,562 and 713,750 shares at September 30, 2025 and December 31, 2024, respectively 5,766 7,138 Common stock, $ 0.001 par value; authorized – 500,000,000 shares; 211,101,313 shares issued and 211,101,313 and 172,913,813 outstanding as of September 30, 2025 and December 31, 2024, respectively 211,101 211,101 Shares to be issued 6,093 5,476 Additional paid-in capital 58,809 818,577 Accumulated deficit ( 2,298,252 ) (

View Full Filing

View this 10-Q filing on SEC EDGAR